Jaundice

Jan 28, 2020

The Global Bilirubin Blood Test Market is expected to grow by USD 562.5 mn during 2020-2024, progressing at a CAGR of 8% during the forecast period

Dec 04, 2018

Little Sparrow Technologies Wins Patent for Humanity 2018 Award from the US Patent and Trademark Office

Nov 07, 2018

Mirum Pharmaceuticals Secures $120 Million in Series A Financing to Develop Phase 3-Ready Maralixibat for Rare Liver Diseases

May 14, 2018

CytoSorb® Adds Bilirubin and Myoglobin Reduction to European Union Approved Indications for Use

Feb 23, 2018

Mallinckrodt Receives FDA Acceptance of Stannsoporfin New Drug Application Filing

Jan 04, 2018

Mallinckrodt Completes Stannsoporfin New Drug Application Filing

Sep 25, 2017

Mallinckrodt Completes Acquisition of InfaCare Pharmaceutical Corporation and Stannsoporfin, its Proprietary Therapy in Late-Stage Development for Newborns at Risk for Severe Jaundice

Aug 04, 2017

Mallinckrodt To Acquire InfaCare Pharmaceutical Corporation And Stannsoporfin, Its Proprietary Therapy In Late-Stage Development For Treatment Of Newborns At Risk For Developing Severe Jaundice